Health Condition 1: D000- Carcinoma in situ of lip, oral cavity and pharynx Health Condition 2: C719- Malignant neoplasm of brain, unspecified Health Condition 3: C189- Malignant neoplasm of colon, unspecified Health Condition 4: C340- Malignant neoplasm of main bronchus Health Condition 5: C508- Malignant neoplasm of overlappingsites of breast Health Condition 6: C538- Malignant neoplasm of overlappingsites of cervix uteri Health Condition 7: C61- Malignant neoplasm of prostate Health Condition
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
VRRX Therapeutics Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Volunteers 18 years of age and older who are being evaluated andor treated for cancer at Paterson Cancer Centre Chennai who have a diagnosed solid tumor through Histopathological analysis
Exclusion criteria
Exclusion criteria: Volunteers with active andor uncontrolled infections or who are still recovering from a viral or bacterial or fungal infection Volunteers who are actively febrile patients with uncertain aetiology of febrile episode Patients who don’t consent for biopsy procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accrual ceiling achieved for tissue collection and tumor similis culture from accrued tissue Time frame 12 months from initial collection of tissue sample Collation of images molecular pathology data and tumor similis treatment response for artificial intelligence objectivesTimepoint: 6 and 12 months from first enrolled patient | — |
Secondary
| Measure | Time frame |
|---|---|
| Automated molecular recognition of histopathology verified and correlated with therapy outcomesTimepoint: 12 months;Obtained tumor similis culture data correlated with volunteer therapy outcome dataTimepoint: 12 months;Volunteer therapy outcome data obtained for all tissue collected.Timepoint: 6 and 12 months | — |
Countries
India
Contacts
Public ContactDr Ishaan Jagan
VRRX Therapeutics Pvt Ltd
Outcome results
None listed